Table 3.
Predictive factors for rebleeding in nonvariceal hemorrhage.
Variable | Rebleeding (P-value) | Mortality (P-value) | ||||
---|---|---|---|---|---|---|
OR | 95% CI | P-value | OR | 95% CI | P-value | |
Severe anemia | 2.00 | 1.13–3.52 | .001 | 4.00 | 2.10–6.75 | <.0001 |
Age > 60 | 1.10 | 0.99–1.35 | .02 | 1.15 | 0.99–1.89 | .001 |
Aspirin | 1.00 | 0.99–1.00 | .08 | 1.00 | 0.99–1.15 | .009 |
Anticoagulants | 2.00 | 1.52–2.51 | .87 | 1.08 | 1.00–1.90 | .04 |
Antiplatelets | 3.50 | 1.02–5.20 | .90 | 1.00 | 0.89–1.15 | .01 |
Other NSAID’s | 1.70 | 1.10–3.40 | .06 | 1.30 | 1.15–2.10 | .01 |
Hemorrhagic shock | 1.10 | 1.00–1.25 | .05 | 3.40 | 1.34–6.50 | <.0001 |
CI = confidence interval, NSAID = non-steroidal anti-inflatory drugs, OR = odds ratio.